Concepedia

Mandatory Prophylaxis

Mandatory Prophylaxis is a public health intervention within bioterrorism preparedness law that compels individuals to receive preventive medical treatment, such as vaccines or antimicrobial agents, during a declared threat, distinguishing it from voluntary prophylaxis by its legally enforced nature.

19

Publications

702

Citations

124

Authors

80

Institutions

Publications per year

2017–2026

6

Parents

Publications

19

Phase I trial of isatuximab monotherapy in the treatment of refractory multiple myeloma

Thomas G. Martin, Stephen A. Strickland, Martha Glenn et al. · Blood Cancer Journal · 2019 · 107 citations · Full text

, , +15

Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: the CONTROL trial

CH Barcenas, Sara A. Hurvitz, Jack A. Di Palma et al. · Annals of Oncology · 2020 · 106 citations · Full text

, , +17

Update: Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001.

PubMed · 2001 · 100 citations

, , +12

Preventing Ophthalmia Neonatorum

Dorothy Moore, Noni E. MacDonald · Canadian Journal of Infectious Diseases and Medical Microbiology · 2015 · 47 citations · Full text

, , +17

Preventing ophthalmia neonatorum

Dorothy Moore, Noni E. MacDonald · Paediatrics & Child Health · 2015 · 44 citations · Full text

, , +17

1–5 of 19

Authors

124

  1. LM
    Leanne McCulloch

    Washington University in St. Louis, United States

    3 publications · 144 citations

    3

    h-index

  2. RB
    Ron Bose

    Washington University in St. Louis, United States

    3 publications · 144 citations

    3

    h-index

  3. SA
    Sara A. Hurvitz

    University of California, Los Angeles, United States

    3 publications · 144 citations

    3

    h-index

  4. AJ
    A. Jo Chien

    University of California, San Francisco, United States

    3 publications · 144 citations

    3

    h-index

  5. AC
    Arlene Chan

    Curtin University, Australia

    3 publications · 144 citations

    3

    h-index

1–5 of 124

Institutions

80

  1. University of California, San Francisco

    San Francisco, United States

    4 h-index

    8 publications

    501 citations

  2. UCSF Helen Diller Family Comprehensive Cancer Center

    San Francisco, United States

    3 h-index

    6 publications

    382 citations

  3. Washington University in St. Louis

    St Louis, United States

    3 h-index

    3 publications

    144 citations

  4. Brown University

    Providence, United States

    3 h-index

    6 publications

    103 citations

  5. The University of Texas MD Anderson Cancer Center

    Houston, United States

    3 h-index

    12 publications

    1K citations

  6. Puma Biotechnology (United States)

    Los Angeles, United States

    3 h-index

    17 publications

    1.2K citations

  7. Curtin University

    Perth, Australia

    3 h-index

    5 publications

    356 citations

  8. University of California, Los Angeles

    Los Angeles, United States

    3 h-index

    3 publications

    144 citations

1–8 of 80

Venues

  1. PubMed

    Repository · 3 publications · 137 citations

    3

    h-index

  2. 2

    h-index

  3. Annals of Emergency Medicine

    2 publications · 31 citations

    2

    h-index

  4. Blood Cancer Journal

    1 publications · 107 citations

    1

    h-index

  5. Annals of Oncology

    1 publications · 106 citations

    1

    h-index

1–5